期刊文献+

三维适形放疗联合卡培他滨综合治疗局部晚期胰腺癌疼痛的效果 被引量:3

下载PDF
导出
摘要 目的观察三维适形放疗联合卡培他滨综合治疗局部晚期胰腺癌的止疼效果。方法 37例局部晚期胰腺癌患者采用三维适形放疗,45~56Gy,1.8~2Gy/次,5次/周。放疗开始的第l天开始口服卡培他滨,每次1000 mg/m2,2次/d,连用14 d,停药7 d,21 d为一周期,至少用药3个周期以上。结果本组37例患者治疗后疼痛缓解率为81.1%,疼痛改善持续时间平均为128 d。结论三维适形放疗联合卡培他滨口服化疗综合治疗局部晚期胰腺癌有明显的止疼效果,卡培他滨可能有放射增敏作用。
出处 《中国现代药物应用》 2011年第4期34-35,共2页 Chinese Journal of Modern Drug Application
  • 相关文献

参考文献5

二级参考文献15

  • 1Warshaw AL, Femandex-Castillo C. Pancreatic carcinoma[J]. N Engl J Med, 1992,326(3) :455-465.
  • 2Burris H, Moore J, Auderson J, et al. Improvements in survival and clinical benefict with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trail[ J]. J Clin Oncol, 1997,5(10) :2403 - 2413.
  • 3Douglas B, Evans-James L, Abbruzzese-Tyvin, et al. Cancer of the pancereas. In De Vita, ed. Cancer, principles and practice of oncology [ M ]. 5th ed. Philiadphia: Lippincott-raven Press,1997. 1054 - 1087.
  • 4Ishikawa T,Sekiguchi F,Fukase Y,et al.Positive correlation between the efficacy of capecitabine and doxifluridine and the ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumors in human cancer xenografts[].Cancer Research.1998
  • 5Terashima M,Fujiwara H,Takagane A,et al.Role of thymidine phosphorylase and dihydropyrimidine dehydrogenase in tumour progression and sensitivity to doxifluridine in gastric cancer patients[].European Journal of Cancer.2002
  • 6Fujiwaki R,Hata K,Nakayama K,et al.Gene expression for dihydropyrimidine dehydrogenase and thymidine phosphorylase influences outcome in epithelial ovarian cancer[].Journal of Clinical Oncology.2000
  • 7Schuller J,Cassidy J,Dumont E,et al.Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients[].Cancer Chemother.2000
  • 8Hirano Y,Kageyama S,Ushiyama T,et al.Clinical significance of thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in transitional cell cancer[].Cancer Chemother.2003
  • 9Wagman R,Grann A.Adjuvant therapy for pancreatic cancer: current treatment approaches and future challenges[].Surgical Oncology Clinics of North America.2001
  • 10Collie-Duguid ES,Johnston SJ,Boyce L,et al.Thymidine phosphorylase and dihydropyrimidine dehydrogenase protein expression in colorectal cancer[].International Journal of Cancer.2001

共引文献23

同被引文献42

  • 1孟令新,丁兆军,陈希平.热疗联合腹腔热灌注化疗治疗胰腺癌并腹腔积液的疗效观察[J].中华临床医师杂志(电子版),2011,5(7):1923-1927. 被引量:29
  • 2周际昌.实用肿瘤内科学[M].北京:人民卫生出版社,2005:601~610.
  • 3李玉,梁军.三维适形与调强放射治疗的基础与临床[M].北京:北京科学技术出版社,2010:23-45.
  • 4苏翔宇,李苏宜,刘琳.胰腺癌同步放化疗应用进展[J].中国肿瘤,2007,16(11):924-928. 被引量:1
  • 5牛道立,杨波,杨振,等.影像引导调强放射治疗[M].天津:天津科技翻译出版社,2012:319-330.
  • 6Jem al A, S iegel R, Ward E, et al . Cancer statistics, 2009 [J]. CA Cancer J Clin ,2009, 59(4):225 -249.
  • 7Hiroshi Ishii, Junji Furuse, Narikazu Boku, et al. Phase II Study of Gemcitabine Chemotherapy Alone for Locally Advanced Pancreatic Carcinoma: JCOG0506 [J]. dPn J Clin Oncol ,2010,40(6) :573.
  • 8Cereda S, Rognone A, Ghidini M, et al . A randomized phase II trial of two different four drug combinations in advanced pancreatic adenocarcinoma: Cisplatin, capecitabine, gemcit- abine plus either epirubicin or docetaxel[J]. J Clin Oncol , 2009, 27(10): 4614.
  • 9Adamczyk KA, Klein-Story S, Tehrani MM, et al . Characterization of soluble and exosomal forms of the EGFR released from pancreatic cancer cells[J]. Life Sci ,2011, 89(9-10) : 304-312.
  • 10Aggarwal S,Yadav S,Gupta S. EGFR targeted PLGA nanop- articles using gemeitabine for treatment of pancreatic cancer [J]. JBiomedNanotechnol ,2011,7(1) : 137-138.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部